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This personal account describes our studies regarding peptide synthesis in ionic liquids 
(PEPSIL). In addition, we summarize our experiments in which the use of ionic liquids gives simple 
and promising access to unnatural amino acids in an enantiomerically enriched form. Extension of 
PEPSIL method to complex structures such as cyclopeptides is also discussed. Some of these 
cyclopeptides are the direct precursors of bioactive and pharmaceutical compounds. 
________________________________________________________________________________ 
Introduction 
The strong potential of ionic liquids for 
organic synthesis has been demonstrated since 
the beginning of the century [1,2]. As soon as 
appeared the seminal contributions in this field, 
we imagined that the use of ionic solvents 
would be especially promising for amino acids 
and peptides chemistry, which remains a major 
challenge for bio-organic and pharmaceutical 
applications [3, 4]. This account highlights our 
studies regarding peptide synthesis in ionic 
liquids (PEPSIL). In addition, experiments in 
which the use of ionic liquids gives simple and 
promising access to unnatural amino acids in an 
enantiomerically enriched form are summarized. 
Extension of PEPSIL method to complex 
structures such as cyclopeptides is also 
discussed: some of these cyclopeptides are the 
direct precursors of bioactive and 
pharmaceutical compounds. In the final part, 
our discovery of a new coupling agent allowing 
the development of waste-free peptide coupling 
is disclosed. 
Results and discussion 
1. Synthesis and resolution of unnatural 
amino acids 
The access to unnatural amino acids via 
Strecker reactions in ionic media has been 
described by several groups [5-8]. According to 
the authors, the expected amino nitriles were 
obtained in high yields by means of three 
component reactions between aldehydes, 
amines, and trimethylsilyl cyanide. The ionic 
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liquids were recycled and reused several times 
without loss of reactivity. 
Since these syntheses obviously yielded 
the racemic mixtures of the compounds, we 
immediately wondered if ionic solvents could 
be helpful for their enantiomeric resolution. In 
this respect, we rapidly focused on 
enantioselective liquid-liquid extraction (ELLE) 
as a promising and innovative method for this 
purpose. 
ELLE method combines in a single 
technique the concepts of resolution (i.e.: 
enantiomeric separation of a racemic mixture) 
and of biphasic extraction [9]. The success of 
such a procedure implies two important 
requisites:  
i. The generation of diastereomeric 
complexes of the extractant with the 
enantiomers, formed by means of 
intermolecular interactions (ion 
pairing, hydrogen bonding, –
interactions, dipolar and Van der 
Waals interactions).  
ii. The existence of two (at least 
partially) immiscible phases. 
This type of process presents high 
scalability, recyclability and easy handling. 
ELLE nowadays can be combined with 
multistage countercurrent cascade technology. 
The main challenge in the field is the 
development of chiral hosts, which must be easy 
to obtain and able to display high selectivity for 
a wide range of substrates. In this context, we 
assumed that chiral ionic liquids (CILs) could 
be excellent candidates since they could act both 
as the solvent and the chiral selector. Also, 
using a hydrophobic CIL layer, combined with 
water extraction, would perfectly match the 
principles of green chemistry. 
The first example of CILs being 
simultaneously used as the solvent and the 
chiral selector in ELLE process was reported by 
Tang et al [10] with enantiomeric excess up to 
50% for a single-step extraction. 
Enantioselective enrichment of racemic amino 
acids was achieved through ligand-exchange via 
copper complexes of CILs.  
Simultaneously, we examined a possible 
alternative process of ELLE without using any 
metal ion. In this context  we were wondering 
about the outcome of the chiral anion of the 
CIL, like a tartrate moiety provided by our 
methodology [11], when exposed to a racemic 
counter-ion. Could we expect chiral 
recognition?  
We first examine pipecoloxylidide as 
model substrate [12]. The (S) enantiomer of this 
molecule is the precursor of a family of local 
anaesthetics. The first step was the preparation 
of the corresponding racemic NTf2 salt, 
obtained in quantitative yield (Figure 1). 
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Figure 1. Preparation of the starting racemic 
pipecoloxylidide salt. 
 
The biphasic chiral extraction system 
was created by mixing the chiral ionic liquid 
[PBu4]2[(R,R)-Trtr] (Trtr = tartrate, Figure 2) 
prepared according to [11], and the racemic 
substrate (R,S)-[HPip][NTf2] in the commercial 
hydrophobic IL [omim][NTf2]. The IL phase 
was mixed for 2 hours in order to allow the 
chiral host and the racemate to interact. Water 
was then added and the biphasic system was 
stirred for an additional 12 hours. Thanks to the 
gap in hydrophilicity between the various ions 
present in the mixture, we observed a complete 
ion metathesis: the hydrophobic 
tetrabutylphosphonium and bis-triflimide ions 
combined in the IL phase, while the hydrophilic 
tartrate and ammonium ions preferred the 
aqueous layer. The overall process resulted in 
the selective extraction of the (S)-enantiomer of 
pipecoloxylidide, which is precisely the 
eutomeric stereoisomer in this series (Figure 2). 
Worthy of note is that incubation time 
and temperature control at 50°C were required, 
as ee drops if incubation is performed at lower 
or higher temperature, and no ee is observed 
without incubation. Thus, the best conditions 
yielded 30% ee for a single extraction. 
This is the first example of the use of 
chiral ionic liquids in ELLE method in the 
absence of any metallic ions. Full results for this 
study were reported elsewhere [13]. 
 
 
 
Figure 2. ELLE process in ionic liquid. 
 
2. Peptide synthesis in ionic liquids 
(PEPSIL) 
The different aspects of peptide 
synthesis in molecular solvents have been 
extensively reviewed [14-16]. Nevertheless, no 
reports of the controlled homogeneous chemical 
peptide coupling in ionic liquids were disclosed 
in the literature before 2004. Yet, we expected 
this approach to be of great potential because of 
the solubility of amino acid derivatives in ionic 
media. We also believed that the coupling could 
be favored by using hydrophobic ionic liquids, 
as well as by stabilization of the charged 
coupling reagents and reaction intermediates in 
these media [17-20]. 
We thus examined peptide coupling in 
ionic liquids with the modern coupling agents 
HATU and BOP that we selected for their 
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structural similarities with ionic solvents (Figure 
3). We expected those reagents to be easily 
dissolved and stabilized in ionic liquids, as well 
as their inherent by-products (Figure 3). As a 
consequence, they may provide slow but 
selective reactions. 
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Figure 3. Coupling reagents and their residual 
components. 
 
We decided to first focus on dipeptide 
formation via coupling of quaternary -amino 
acids, which are generally more reluctant than 
their tertiary proteinogenic congeners (Figure 
4). After optimization of the reaction conditions 
and extraction process, good yields were 
observed, which compared favorably with 
yields in molecular solvents such as 
dichloromethane or THF [17-20]. Interestingly, 
crude dipeptides were obtained with higher 
purity in ionic liquids. This confirmed our 
hypothesis of a more selective chemical 
pathway due to the stabilization effect of the 
ionic liquid on both the coupling reagent and the 
charged intermediates. 
 
PAA1 + AA2OMe
HATU or BOP
[bmim][PF6]
DIEA
PAA1-AA2OMe
H2N COOH H2N COOHH2N COOH
AA1 & AA2:
dipeptide
 
Figure 4. Dipeptide synthesis in [bmim][PF6] 
 
After the publication of our preliminary 
results [17], three independent studies 
confirmed the interest of peptide coupling in 
ionic solvents, and highlighted the main 
conclusions of our studies. Yen and Chu 
described the synthesis of diketopiperazines in 
[bdmim][PF6], under microwave irradiation 
[21]. Sega and coworkers published the 
synthesis of the dipeptide Cbz-Phe-Ser-OMe in 
90% yield [22]. More recently, Poletti and 
Giannini extended the method to the 
unprecedented use of ionic liquids in the 
synthesis of peptide nucleic acids (PNA) 
oligomers, including the application of the 
supported ionic liquid phase (SILP) technique 
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[23]. 
Having in hands the proof of concept, 
we decided to embark on the synthesis of longer 
and more elaborated peptidic sequences [20, 
24]. Indeed, standard peptide couplings still 
show some drawbacks such as a rather low 
productivity in solid-phase methods, as well as 
limited chain construction in homogeneous 
synthesis. Thus, a promising study was to 
evaluate the construction of longer peptide 
sequences, including cyclopeptides that are 
generally more demanding. We first prepared 
the tetrapeptide Z-(Gly-(R)-MPG)2-OMe using 
HATU as coupling reagent and the previously 
prepared dipeptides, according to the same 
protocol we previously used for the synthesis of 
dipeptides (Figure 5). 
 
ZGly-MPG + Gly-MPG-OMe
HATU, DIEA
[bmim][PF6]
65°C
ZGly-MPG -Gly-MPG-OMe
83 %
H2N COOH
Me
(R)-MPG
Me
 
Figure 5. Synthesis of tetrapeptide Z-(Gly-(R)-MPG)2-
OMe. 
 
We were delighted to observe a high 
conversion, better than in THF [20, 24]. Two 
different samples of the protected tetrapeptide 
were then individually deprotected on the N-
terminal position and on the C-terminal one 
using standard procedures, in quantitative and 
85% yield respectively. Those two fragments 
were then coupled using HATU as activating 
agent. The corresponding linear octapeptide was 
easily secured in 83% yield (Figure 6), a similar 
result to the one observed in THF [20, 24]. 
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Figure 6. Synthesis of linear octapeptide Z-(Gly-(R)-
MPG)4-OMe. 
 
Each of the terminal functions of the 
octapeptide were then deprotected, giving the 
required precursor for cyclisation. Both 
deprotection steps proved efficient with ca 80% 
yields [20, 24]. 
The final step of this study was the 
cyclisation reaction yielding the corresponding 
cyclooctapeptide (Figure 7) in [bmim][PF6] as 
solvent. Dimerization is a common issue in 
macrocyclisation reactions that is generally 
circumvented by means of high dilutions. 
However, since ionic liquids are highly viscous 
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liquids, presenting a very low diffusivity, we 
showed that the reaction could proceed at higher 
concentrations of the linear octapeptide than in 
molecular solvents (10-2 M in [bmim][PF6] vs 
10-4 M in DMF). Indeed, using BOP as the 
coupling agent achieved an exciting result, 
delivering the targeted cyclopeptide in 85% 
yield [20, 24]. 
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Figure 7. Targeted cyclo(Gly-(R)-MPG)4, (cGM). 
 
As highlighted before, one of the most 
interesting aspects of PEPSIL is the high purity 
of the crude material. This is due, at least in 
part, to the ability of ionic liquids to retain in 
solution the residual components of the 
coupling agents (HOAt, tetramethylurea, 
HMPA, Figure 3). 
 Our most recent application of PEPSIL 
method is the synthesis of cyclopeptides 
containing either biaryl ether or aryl-aryl 
linkages [25]. These compounds have attracted 
considerable interest because of the significant 
biological activities that most of them exhibit, 
including antimicrobial and cytotoxic activities 
[26]. However, the synthesis of these molecules 
remains a genuine challenge [27]. Two 
representative examples of these structures are 
shown in Figure 8. 
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Figure 8. Bioactive cyclopeptides derived from tyrosine. 
 
The biaryl ether moieties come from the 
side chains of tyrosine. Several di- and tri-
peptides derived from tyrosine have thus been 
synthesized in various ionic liquids. The most 
convenient one is [bmim][PF6], due to its 
hydrophobicity facilitating the extraction of the 
synthesized peptides. Some typical results are 
depicted in Figure 9 [25]. 
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Figure 9. Di- and tripeptides obtained from tyrosine in 
[bmim][PF6]. 
 
Again we observed better results when 
using BOP instead of HATU as coupling 
reagent, a behavior that we previously discussed 
[24]. To the best of our knowledge, those results 
are the first PEPSIL examples for amino acids 
bearing a functionalized side chain. Full details 
for this study will be published elsewhere [25, 
28]. 
3. CBEIT: a new coupling reagent for 
waste-free PEPSIL method 
The results reported so far highlighted 
the strong potential of PEPSIL method. 
Nonetheless, we thought that the use of ionic 
liquids in peptide synthesis could be even more 
advantageous than just playing the role of new 
solvents. 
Indeed, we are now using an ionic 
coupling reagent with ionic liquids in a protocol 
where the only by-products are carbon dioxide 
and ethylimidazolium triflate, a proper ionic 
liquid that can play the role of the solvent. This 
innovative self-regenerating process is part of 
our current studies about synthesis in ionic 
liquid only (SILO) [29]. Such an approach, 
which paves the way to waste-free peptide 
synthesis, is of particular interest in the context 
of sustainable chemistry. 
Our inspiration came from Rapoport 
group’s results published some years ago [30, 
31]. The authors described 1,1’-carbonylbis-(3-
methylimidazolium) triflate (CBMIT, Figure 
10) as an efficient coupling reagent. The 
generated by-products were only carbon dioxide 
and methylimidazolium triflate ([H-
MIM][TfO]). As this salt is not a room 
temperature ionic liquid (high melting point and 
viscosity), we looked for a similar reagent 
displaying comparable reactivity while giving a 
by-product being liquid at low temperature. In 
this regard, we showed that the homologous 
CBEIT gave as resulting salt the ionic liquid [H-
EIM][TfO], with a low melting point of 8°C and 
an acceptable viscosity [32, 33]. 
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Figure 10. Ionic coupling reagents and their 
corresponding by-products. 
 
CBEIT was readily obtained by reaction 
of CDI with ethyl triflate, with quantitative 
yield and no need for further purification before 
use (Figure 11). 
 
N
N N
N
O
EtO
S
CF3
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N
N N
N
O
EtEt
TfOTfO
CBEIT, 99%
(2 equiv)
 MeNO2
CDI
 
Figure 11. Synthesis of CBEIT. 
We then focused on a general method 
giving only carbon dioxide and [H-EIM][TfO] 
as by-products. To achieve this goal, we needed 
to prepare the starting protected amino acids in 
a way avoiding any other by-products. As a 
result, we prepared a series of unprecedented 
methyl amino ester triflates by direct alkylation 
of amino acids with methyl triflate (C-
protection, Figure 12). In parallel experiments, 
benzyl alcohol and t-butanol were reacted, first 
with CBEIT, and in turn with amino ester salts 
in the presence of ethyl imidazole to give the 
corresponding carbamates in good yields (N-
protection, Figure 12). 
H3N COOMe
TfO
H2N COOH
MeO
S
CF3
OO
quantitative
CBEIT
R2OH
N
H
COOH
R3
R2O
O
R2O N
N
O
Et
TfO
85%
H3N COOMe
R3
CH3NO2, 0°C, 1 h
TfO
NNEt
C-protection N-protection
1.
2. NaOH then aq. HCl
80%
R1
R1
Figure 12. N- and C- protection of starting amino acids. 
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The key step was the coupling of C- and 
N-protected amino acids using CBEIT as the 
coupling agent and ethyl imidazole as a base 
able to liberate the amino ester salt. Two 
representative results are shown in Figure 13. 
The dipeptides were obtained with yields as 
high as 75% [32, 33]. 
Z
N
H
COOH
H3N COOMe
TfO
CBEIT 25°C, 24h
Z
N
H
H
N COOMe
O
75%
NNEt
Z
N
H
COOH
H3N COOMe
TfO
Z
N
H
H
N COOMe
O
55%
Figure 13. “Waste-free” peptide couplings. 
We checked that no racemization occurred 
during the process [32, 33]. The ionic liquid [H-
EIM][TfO] was recovered and purified by 
standard procedure in ca 70% un-optimized 
yield. Figure 14 summarizes the overall strategy 
for this new waste-free peptide synthesis. 
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+ CBEIT
N
H
R1
R2O
O
O
H
N COOMe
R3
N
N N
N
O
EtEt
TfOTfO
CBEIT
+
+ [H-EIM][TfO]
Figure 14. Overall protocol for waste-free peptide 
synthesis. 
Conclusions 
In conclusion, this account summarizes 
three innovative approaches for peptide 
chemistry using ionic liquids, while more 
exhaustive data in this field were reviewed 
elsewhere [19, 34, 35]. 
 First, ELLE using CILs is demonstrated 
as a very promising and eco-friendly method for 
liquid-liquid resolution of amino acids. 
Second, PEPSIL proves to be a powerful 
alternative for peptide synthesis. The 
construction of elaborated structures is 
disclosed, showing the high potential of the 
method. 
Third, CBEIT is an excellent coupling 
reagent for efficient and “waste-free” peptide 
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synthesis. The only by-products are carbon 
dioxide and an ionic liquid that may act as the 
solvent. Not only the peptide coupling itself is 
realized in such conditions, but also the 
necessary protections of the starting amino 
acids. 
When considered together, these three 
studies highlight the rich potential of ionic 
liquids as tools and solvents for peptide 
chemistry. Although these approaches are still 
in infancy, we believe that future insights and 
discoveries in this field will afford powerful 
alternative methods for amino acids chemistry 
and peptide synthesis. 
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